In the summer semester 2024 (from May 2024 to July 2024), we are happy to once again host a digital journal club to read and discuss a selection of methods-focused scientific articles.

We will meet on a Wednesday toward the end of each month, at 4:00 PM in Berlin, Germany, on Zoom. JClub meetings are typically 90 minutes long. Since the meeting format is online, participants from any location and time zone are welcome to join!

The official registration form for the summer semester is now closed. However, we still have a few spots open. If you are interested in joining the JClub or have any other questions, please contact us at bemcolloquium@charite.de.

Meeting Dates, Session Leaders, and Reading Assignments

May 22, 2024 | Chisato Ito & Mascha Kern
Galea S, Hernán MA. Win-Win: Reconciling Social Epidemiology and Causal Inference. Am J Epidemiol. 2020 Mar 2;189(3):167-170. https://doi.org/10.1093/aje/kwz158.
and
Robinson WR, Bailey ZD. Invited Commentary: What Social Epidemiology Brings to the Table-Reconciling Social Epidemiology and Causal Inference. Am J Epidemiol. 2020 Mar 2;189(3):171-174. https://doi.org/10.1093/aje/kwz197.

June 26, 2024 | Tobias Kurth
Ross RK, Zivich PN, Stringer JSA, Cole SR. M-estimation for common epidemiological measures: introduction and applied examples. Int J Epidemiol. 2024 Feb 14;53(2). https://doi.org/10.1093/ije/dyae030.

July 17, 2024 | Toivo Glatz & Narges Ghoreishi
Yland JJ, Wesselink AK, Lash TL, Fox MP. Misconceptions About the Direction of Bias From Nondifferential Misclassification. Am J Epidemiol. 2022 Jul 23;191(8):1485–95.April 19, http://dx.doi.org/10.1093/aje/kwac035.

In the winter semester 2022/23 (from October 2022 to February 2023), we are happy to once again host a digital journal club to read and discuss a selection of methods-focused scientific articles.

We will meet every third Wednesday of the month (exceptions: no meeting in December, and in January, we meet during the fourth week), at 4:00 PM in Berlin, Germany, on Zoom. JClub meetings are typically 90 minutes long. Since the meeting format is online, participants from other locations and time zones are welcome to sign up!

If you are interested in participating, please sign up by September 23, 2022 using the following link: https://forms.gle/ifUN4iQBF577nsJL9. Please note that space is limited, and we may need to put you on a waiting list, depending on interest. Charité Health Data Sciences PhD Program students will be prioritized. If you have any questions, please contact us at bemcolloquium@charite.de. 

Meeting Dates, Session Leaders, and Reading Assignments

October 19, 2022 | Tobias Kurth & Chisato Ito

Bellamy D, Hernán MA, Beam A. A structural characterization of shortcut features for prediction. Eur J Epidemiol 2022;37:563–8. https://doi.org/10.1007/s10654-022-00892-3.

November 16, 2022 | Jess Rohmann & Imke Mayer

Ankan A, Wortel IMN, Textor J. Testing Graphical Causal Models Using the R Package “dagitty.” Curr Protoc 2021;1:e45. https://doi.org/10.1002/cpz1.45.

January 25, 2023 | Toivo Glatz

Lu J, Meyer S. A zero-inflated endemic-epidemic model with an application to measles time series in Germany. arXiv [statME] 2022. https://arxiv.org/abs/2201.07285.

February 15, 2023 | Marco Piccininni

Inoue K, Ritz B, Arah OA. Causal Effect of Chronic Pain on Mortality Through Opioid Prescriptions: Application of the Front-Door Formula. Epidemiology 2022;33:572–80. https://doi.org/10.1097/EDE.0000000000001490.

Starting this fall, from September 2021 to February 2022, we will read and discuss a collection of articles suggested by BEMC participants and selected by the BEMC team to hone in on specific epidemiological method topics that are often overlooked, misunderstood, controversial, or just simply cannot be revisited enough!

We will meet every third Wednesday of the month at 4:00 PM Berlin time via Zoom. Participants from other locations and time zones are welcome to sign up! BEMC JClub meetings are typically 90 minutes long.

If you are interested in participating, please sign up by September 1st, 2021 using the following link: https://forms.gle/8RvUt1ZSKzfUXVXB8. Please note that space is limited, and we may need to put you on a waiting list, depending on interest. Charité Health Data Sciences PhD Program students will be prioritized. If you have any questions, please contact bemcolloquium@charite.de. 

September 15, 2021

Breskin A, Cole SR, Westreich D. Exploring the Subtleties of Inverse Probability Weighting and Marginal Structural Models. Epidemiology. 2018 May;29(3):352–5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882514/?report=classic

October 20, 2021

Whitcomb BW, Naimi AI. Defining, Quantifying, and Interpreting “Noncollapsibility” in Epidemiologic Studies of Measures of “Effect.” Am J Epidemiol. 2021 May 4;190(5):697–700. https://academic.oup.com/aje/article/190/5/697/6030882

November 17, 2021

Rojas-Saunero LP, Hilal S, Murray EJ, Logan RW, Ikram MA, Swanson SA. Hypothetical blood-pressure-lowering interventions and risk of stroke and dementia. Eur J Epidemiol. 2021 Jan;36(1):69–79. https://link.springer.com/article/10.1007/s10654-020-00694-5

December 15, 2021

Vable AM, Diehl SF, Glymour MM. Code Review as a Simple Trick to Enhance Reproducibility, Accelerate Learning, and Improve the Quality of Your Team’s Research. Am J Epidemiol [Internet]. 2021 Apr 8; Available from: http://dx.doi.org/10.1093/aje/kwab092 

January 19, 2022 

Corraini P, Olsen M, Pedersen L, Dekkers OM, Vandenbroucke JP. Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators. Clin Epidemiol. 2017 Jun 8;9:331–8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476432/

February 16, 2022

Krieger N, Davey Smith G. The tale wagged by the DAG: broadening the scope of causal inference and explanation for epidemiology. Int J Epidemiol. 2016 Dec 1;45(6):1787–808. https://academic.oup.com/ije/article/45/6/1787/2617188

The BEMC talk in June 2020 titled “Disorderly World of Diagnostic and Prognostic Models for Covid-19” was presented by Laure Wynants. The project started at the beginning of the pandemic. The author read a tweet from somebody asking for advice on building a prediction model for COVID-19 patients. There is a clinical need for prediction models to improve care and reduce costs. If a good model is built it could help allocate core resources for clinician to answer these questions (1) who needs to undergo further diagnostic work-up, (2) to speed up CT interpretation, (3) who should be admitted to ICU?

Their first review named “Prediction models for diagnosis and prognosis of covid-19: systematic review of critical appraisal” took 18 days from building the idea to being accepted. This work involved 14 experienced risk modelling reviewers. Screening and data extraction was done independently by 2 reviewers. Laure Wynants and her research team did not only look at the published materials but also pre-prints. The number of pre-prints was much bigger than traditional scientific publishing. Although there are many issues around pre-prints, given the pandemic situation, the traditional scientific publishing is not keeping up the speed of scientific research that’s being done. The scope of the review is having prediction models for diagnosing coronavirus diseases 2019 (covid-19) in patients with suspected infection, for prognosis of patients with covid-19, and for detecting people in the general population at risk of being admitted to hospital for covid-19 pneumonia. Clinical prediction models will support clinical decision-making for individual patients by combining and giving appropriate weights to several inputs (e.g., CT image characteristics, signs and symptoms, lab test results, demographics …). Laure Wynants and her research team used PROBAST tools to assess the risk of bias and use CHARMS for data extraction. Then the PRISMA and TRIPOD were used for the author’s reporting. With collaboration with Cochrane prognosis methods group and the expanded group, the first round was run with an AI tool. The first round included 107 studies with 145 models which proposed diagnostic of prognostic model for covid-19. Among 107 papers, there were 87 preprints and 20 peer-reviewed and published. Among those models, 4 model for detecting people at risk in general population, 91 diagnosis model for COVID-19 or covid-19 pneumonia and 50 prognosis models for predicting mortality risk, progression to severe disease, or composite outcomes.

Contributed by: Pham Thi Thu

Mastering R for Epidemiologic Research with Malcolm Barrett

Since it was so well received by many BEMC attendees last year, we wanted to share with you that there are still a few spots left in this summer break intensive short course. The fully digital course is designed for researchers, public health professionals, epidemiologists, and clinicians who want to improve their R coding skills, learn modern tools in the R ecosystem, like the tidyverse and Shiny, and maybe even think about the first steps of developing their own packages in R.

• Course language: English
• ECTS points: 3
• Course Fee: 510€ for students, 750€ for other participants
• 31.8.-11.9.2020, asynchronous online with optional live “office hours”

If you are interested, please click on this link to find out more or register.

We have now moved online, we still have the same line-up of speakers and they are presenting their interesting material online on our Youtube channel.

Check out our May event here:

Jclub is still ongoing, simply contact us at bemcolloquium(at) charite.de for the Zoom details.

Dear Berlin-area Epidemiological Methods Enthusiasts,

We regret to inform you that in light of the current situation with SARS-CoV-2 / COVID-19, ALL BEMC Talks and JClub events must be cancelled until further notice.

As epidemiologists, we feel this is the right move. It is also in line with declaration of measures for scientific activities released by the Berlin Senate. For more information, see: https://www.berlin.de/sen/wissenschaft/aktuelles/pressemitteilungen/2020/pressemitteilung.905804.php

In the meantime, if you are missing the BEMC, you can subscribe to our new BEMC YouTube channel and catch up on our past 2 BEMC Talks: https://www.youtube.com/channel/UCJP9KScMBRC0reDr1tTXrpg/featured

We are currently working on bringing you more talks electronically even if we cannot meet in person. Stay tuned!

Regards,

Your BEMC Team

Over the years, we have received several requests to start filming our talks, and we were always a little bit hesitant.  It is labor intensive, potentially distracting and not attractive to some speakers. Although we hope to reach those outside of Berlin with this effort, maybe our local attendance will drop. In spite of these initial fears and challenges, after testing some options, we have decided that we will give it a (provisional) go with an improvised, rather rudimentary setup. 

Where to start? We have asked previous presenters if they would prefer live streaming or video recording, and streaming came out just on top, however, most were also ok with recording. We then asked our target audience, who strongly preferred recorded video. The BEMC Talk videos will be available for everybody wherever, whenever, potentially multiplying the number of people who benefit from the extra effort. So, video it is. 

Of course, we understand that not all presenters will feel comfortable with recording. Sometimes it is because of the work that they are presenting; sometimes it is because the thought of being online until the end of time is a bit daunting. We will respect their wishes if they want the talk to stay completely offline.  However, we will try to work with speakers in such cases to record parts of their talks, when possible, and ask them for a green light after we have shown them the edited video. With this approach we think that a good chunk of the BEMC talks will end up on the internet. Even though the video and sound quality will not be top notch without professional equipment, we hope this first step will still be well received.  

We hope that a lot of people will benefit from our videos. Of course, we will keep an eye on the view counts and watch for useful feedback in the comments section on our Youtube page, but please feel free to get in touch directly via Twitter or using our “Contact us” page to let us know what you think. 

All the best and thanks for your continued support, 

The BEMC team

The talk’s title is “A New Approach to the Generalizability of Randomized Trials” presented by Dr. Anders Huitfeldt.

To extrapolate causal effects from one setting (the study population of a RCT) to another setting (a clinically relevant target population) we need to justify some parameters. For example, we have to see if the conditional effect parameter in the target population is equal to the corresponding parameter in the study population. Known as the “effect homogeneity”. The effect homogeneity parameter occurs not only between the study population and the target population but also between two groups in the RCT’s population. The principle of extrapolating causal effects is that, because we have a randomized trial in the study population, we know what happens in this population if everyone takes the drug and what if they don’t take the drug. In addition, because the drug is not available in the target population we know what happens if they don’t take the drug. Then, we target to use the above information in combination with homogeneity assumption to predict what happens if someone in the target population don’t take the drug. However, the different definition of “effect homogeneity” leads to a different empirical prediction. Traditional approaches for it are: Effect Measure Modification, Forest plots, Cochran’s Q, I2. These approaches contain some shortcomings which can be reduced (eg. No biological interpretation). That is why a method which can be used to determine choice between effect measures is necessary. The COST parameter would be a new class of causal models for the purpose. The COST parameter has many advantages as effect quality measuring because of (1) a clear biological interpretation, (2) the effect of a drug is determined by gene, (3) Baseline risk independence. Finally, there is still controversial among methodologists about using COST parameter as an approach to determining the appropriate choice of scale if effect homogeneity is considered in terms of measures of effect.